Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1894 1
1896 1
1925 1
1926 1
1928 1
1929 1
1932 2
1933 1
1934 2
1935 2
1936 2
1937 1
1945 3
1946 10
1947 17
1948 18
1949 18
1950 32
1951 37
1952 30
1953 60
1954 52
1955 77
1956 80
1957 69
1958 68
1959 68
1960 76
1961 84
1962 112
1963 172
1964 237
1965 190
1966 207
1967 246
1968 256
1969 274
1970 273
1971 289
1972 278
1973 313
1974 263
1975 270
1976 299
1977 253
1978 231
1979 287
1980 259
1981 262
1982 342
1983 304
1984 376
1985 435
1986 467
1987 563
1988 569
1989 740
1990 820
1991 843
1992 849
1993 1098
1994 1123
1995 1178
1996 1268
1997 1519
1998 1634
1999 1753
2000 2008
2001 2179
2002 2446
2003 2613
2004 2948
2005 3202
2006 3216
2007 3190
2008 3363
2009 3499
2010 3689
2011 4045
2012 4116
2013 4252
2014 4405
2015 4647
2016 4643
2017 4715
2018 4883
2019 4919
2020 5541
2021 4527
Text availability
Article attribute
Article type
Publication date

Search Results

95,362 results
Results by year
Filters applied: . Clear all
Page 1
Pathophysiology of osteoporosis: new mechanistic insights.
Armas LA, Recker RR. Armas LA, et al. Endocrinol Metab Clin North Am. 2012 Sep;41(3):475-86. doi: 10.1016/j.ecl.2012.04.006. Epub 2012 Jun 9. Endocrinol Metab Clin North Am. 2012. PMID: 22877425 Review.
Understanding of the pathophysiology of osteoporosis has evolved to include compromised bone strength and skeletal fragility caused by several factors: (1) defects in microarchitecture of trabeculae, (2) defective intrinsic material properties of bone tissue, (3) defective …
Understanding of the pathophysiology of osteoporosis has evolved to include compromised bone strength and skeletal fragility caused b …
Osteoporosis and fracture risk in older people.
Coughlan T, Dockery F. Coughlan T, et al. Clin Med (Lond). 2014 Apr;14(2):187-91. doi: 10.7861/clinmedicine.14-2-187. Clin Med (Lond). 2014. PMID: 24715132 Free PMC article. No abstract available.
Management of severe osteoporosis.
Miller PD. Miller PD. Expert Opin Pharmacother. 2016;17(4):473-88. doi: 10.1517/14656566.2016.1124856. Epub 2015 Dec 23. Expert Opin Pharmacother. 2016. PMID: 26605922 Review.
INTRODUCTION: Severe osteoporosis represents a disease of high mortality and morbidity. Recognition of what constitutes and causes severe osteoporosis and aggressive intervention with pharmacological agents with evidence to reduce fracture risk are outlined in this …
INTRODUCTION: Severe osteoporosis represents a disease of high mortality and morbidity. Recognition of what constitutes and causes se …
Osteoporosis in elderly: prevention and treatment.
Srivastava M, Deal C. Srivastava M, et al. Clin Geriatr Med. 2002 Aug;18(3):529-55. doi: 10.1016/s0749-0690(02)00022-8. Clin Geriatr Med. 2002. PMID: 12424871 Review.
Osteoporosis is a major clinical problem in older women and men. Almost any bone can fracture as a result of the increased bone fragility of osteoporosis. ...Several other modifiable and nonmodifiable risk factors for osteoporosis have also been identified. T
Osteoporosis is a major clinical problem in older women and men. Almost any bone can fracture as a result of the increased bone fragi
The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil.
Baccaro LF, Conde DM, Costa-Paiva L, Pinto-Neto AM. Baccaro LF, et al. Clin Interv Aging. 2015 Mar 20;10:583-91. doi: 10.2147/CIA.S54614. eCollection 2015. Clin Interv Aging. 2015. PMID: 25848234 Free PMC article. Review.
The reported prevalence of osteoporosis among postmenopausal women in Brazil varies from 15% to 33%, depending on the study methodology and the use of bone densitometry data or self-reporting by participants. ...To reduce the risk of osteoporosis, all post
The reported prevalence of osteoporosis among postmenopausal women in Brazil varies from 15% to 33%, depending on the study me …
Osteoporosis in china.
Wang Y, Tao Y, Hyman ME, Li J, Chen Y. Wang Y, et al. Osteoporos Int. 2009 Oct;20(10):1651-62. doi: 10.1007/s00198-009-0925-y. Epub 2009 May 5. Osteoporos Int. 2009. PMID: 19415374 Review.
SUMMARY: Based on related studies published between 1980 and May 2008, we examine the prevalence of osteoporoses in mainland China, Hong Kong, and Taiwan. Overall, the prevalence of osteoporosis among these Chinese populations remains low compared to other Caucasian …
SUMMARY: Based on related studies published between 1980 and May 2008, we examine the prevalence of osteoporoses in mainland China, H …
Use of bone turnover markers in postmenopausal osteoporosis.
Eastell R, Szulc P. Eastell R, et al. Lancet Diabetes Endocrinol. 2017 Nov;5(11):908-923. doi: 10.1016/S2213-8587(17)30184-5. Epub 2017 Jul 7. Lancet Diabetes Endocrinol. 2017. PMID: 28689768 Review.
However, these markers are subject to several sources of variability, including feeding (resorption decreases) and recent fracture (all markers increase for several months). Bone turnover markers are not used for diagnosis of osteoporosis and do not improve prediction of b …
However, these markers are subject to several sources of variability, including feeding (resorption decreases) and recent fracture (all mark …
Periodontitis and osteoporosis.
Straka M, Straka-Trapezanlidis M, Deglovic J, Varga I. Straka M, et al. Neuro Endocrinol Lett. 2015;36(5):401-6. Neuro Endocrinol Lett. 2015. PMID: 26707036 Review.
Today's knowledge and studies show a firm correlation between osteoporosis and periodontitis, particularly in postmenopausal women. ...The second part of the paper deals with principles of treatment in patients suffering of osteoporosis. Osteoporosis r …
Today's knowledge and studies show a firm correlation between osteoporosis and periodontitis, particularly in postmenopausal w …
Abaloparatide: A new pharmacological option for osteoporosis.
Sleeman A, Clements JN. Sleeman A, et al. Am J Health Syst Pharm. 2019 Jan 25;76(3):130-135. doi: 10.1093/ajhp/zxy022. Am J Health Syst Pharm. 2019. PMID: 30689744 Review.
PURPOSE: The efficacy and safety of abaloparatide, a parathyroid hormone-related protein analog for the treatment of osteoporosis in postmenopausal women at high fracture risk, is reviewed. SUMMARY: A MEDLINE search was conducted for full text English-language artic …
PURPOSE: The efficacy and safety of abaloparatide, a parathyroid hormone-related protein analog for the treatment of osteoporosis in …
Osteoporosis.
Lane JM, Russell L, Khan SN. Lane JM, et al. Clin Orthop Relat Res. 2000 Mar;(372):139-50. doi: 10.1097/00003086-200003000-00016. Clin Orthop Relat Res. 2000. PMID: 10738423 Review.
Osteoporosis is a disorder of decreased bone mass, microarchitectural deterioration, and fragility fractures. Osteoporosis is widespread and can affect people of all ethnic backgrounds and many older women and men. ...
Osteoporosis is a disorder of decreased bone mass, microarchitectural deterioration, and fragility fractures. Osteoporosis is
95,362 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page